Shedding light on the use of colistin: Still gaps to be filled;Luces y sombras en el uso de colistina: falta mucho por conocer

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 29, Issue 4, 2011, Pages 287-296

  Luque, Sonia ^a   Grau, Santiago ^a   Berenguer, Nuria ^a   Horcajada, Juan Pablo ^a   Sorlí, Luisa ^a   Montero, María Milagro ^a   Salas, Esther ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

Colistimethate; Colistin; Drug monitoring; Efficacy; Pharmacokinetic pharmacodynamic; Toxicity

Indexed keywords

COLISTIMETHATE; COLISTIN;

ARTICLE; CLINICAL STUDY; DRUG EFFICACY; DRUG USE; PHARMACODYNAMICS; PHARMACOKINETICS; TOXICITY TESTING;

EID: 79954423958     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2011.02.003     Document Type: Review

References (106)

1. J. Molina, E. Cordero, J. Palomino, and J. Pachón Aminoglucósidos y polimixinas Enf Infecc Microbiol Clin. 27 2009 178 188
2. J. Li, R.L. Nation, J.D. Turnidge, R.W. Milne, K. Coulthard, and C.R. Rayner Colistin: re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections Lancet Infect Dis. 6 2006 589 601
3. Z. Ma, J. Wang, J. Gerber, and R.W. Milne Determination of colistin in human plasma, urine and other biological simples using LC-MS/MS J Chromatogr B. 862 2008 205 212
4. P. Beringer The clinical use of colistin in patients with cystic fibrosis Curr Opin Pulm Med. 7 2001 434 440 (Pubitemid 33065550)
5. M.E. Falagas, and S.K. Kasiakou Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections Clin Infec Dis. 40 2005 1333 1341 (Pubitemid 40570245)
6. B.M. Jansson, M. Karvanen, O. Cars, D. Plachouras, and L.E. Friberg Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step by LC/MC/MS J Pharmaceut Biomed Analysis. 49 2009 760 767
7. P.J. Bergen, J. Li, C.R. Rayner, and R.L. Nation Colistin methanosulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa Antimicrob Agents Chemother. 50 2006 1953 1958 (Pubitemid 43807511)
8. J. Li, R.L. Nation, R.W. Milne, J.D. Turnidge, and K. Coulthard Evaluation of colistin as an agent against multi-resistant gram-negative bacteria Int J Antimicrob Agents. 25 2005 11 25 (Pubitemid 40023341)
9. D.M. Livermore The need for new antibiotics Clin Microbiol Infect. 10 Suppl 4 2004 1 9
10. Agencia Española de Medicamentos y Productos Sanitarios. Disponible en: https://sinaem4.agemed.es/consaem/especialidad.do?metodo= verFichaHtml&codigo=66292&fichaCompleta=S
11. Clinical Trials.gov. U.S. National Institute of Health. Disponible en: http://www.clinicaltrials.gov/ct2/results?term=colistin
12. M.E. Falagas, S.K. Kasiakou, S. Tsiodras, and A. Michalopoulos The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature Clin Med Res. 4 2006 138 146 (Pubitemid 44047368)
13. A.P. Zavascki, and J. Li Infection the Lancet. 8 2008 403 404
14. J. Garnacho-Montero, C. Ortiz-Leyba, F.J. Jiménez-Jiménez, A.E. Barrero-Almodóvar, J.L. García-Garmendía, and M. Bernabeu-Wittell Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP Clin Infect Dis. 36 2003 1111 1118 (Pubitemid 36549630)
15. R. Reina, E. Estenssoro, G. Sáenz, H.S. Canales, R. Gonzalvo, and G. Vidal Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study Int Care Med. 31 2005 1058 1065 (Pubitemid 41125336)
16. R.Y. Hachem, R.F. Chemaly, C.A. Ahmar, Y. Jiang, M.R. Boktour, and G.A. Rjaili Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients Antimicrob Agents Chemother. 51 2007 1905 1911 (Pubitemid 46903072)
17. F.G. Ríos, C.M. Luna, B. Maskin, A. Sáenz Valiente, M. Lloria, and S. Gando Ventilator-associated pneumonia due to colistin susceptible-only microorganisms Eur Respir J. 30 2007 307 313 (Pubitemid 47194183)
18. H. Kallel, L. Hergafi, M. Bahloul, A. Hakim, H. Dammak, and H. Chelly Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study Intensive Care Med. 33 2007 1162 1167 (Pubitemid 47036903)
19. M. Paul, J. Bishara, A. Levcovich, M. Chowers, E. Goldberg, and P. Singer Effectiveness and safety of colistin: prospective comparative cohort study J Antimicrob Chemother. 65 2010 1019 1027
20. R. Gounden, C. Bamford, R. van Zyl-Smit, K. Cohen, and G. Maartens Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections BMC Infect Dis. 9 2009 26
21. A.P. Betrosian, F. Frantzeskaki, A. Xanthaki, and E.E. Douzinas Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia J Infection. 56 2008 432 436
22. A. Rodríguez-Guardado, A. Blanco, V. Asensi, F. Pérez, J.C. Rial, and V. Pintado Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments J Antimicrob Chemother. 61 2008 908 913 (Pubitemid 351426078)
23. M.E. Falagas, P.I. Rafailidis, E. Ioannidou, V.G. Alexiou, D.K. Matthaiou, and D.E. Karageorgopoulos Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients Int J Antimicrob Agents. 35 2010 194 199
24. C.Y. Cheng, W.H. Sheng, J.T. Wang, Y.C. Chen, and S.C. Chang Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections Int J Antimicrob Agents. 35 2010 297 300
25. M. Montero, J.P. Horcajada, L. Sorli, F. Álvarez-Lerma, S. Grau, and M. Riu Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections Infection. 37 2009 461 465
26. M.S. Oliveira, G.V. Prado, S.F. Costa, R.S. Grinbaum, and A.S. Levin Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp J Antimicrob Chemother. 61 2008 1369 1375 (Pubitemid 351753609)
27. V. Pintado, L.G. San Miguel, F. Grill, B. Mejía, J. Cobo, and J. Fortún Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria J Infect. 56 2008 185 190
28. M.E. Falagas, S.K. Kasiakou, D.P. Kofteridis, G. Roditakis, and G. Samonis Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria Eur J Clin Microbiol Infect Dis. 25 2006 596 599 (Pubitemid 44379694)
29. D. Berlana, J.M. Llop, E. Fort, M.B. Badia, and R. Jódar Use of colistin in the treatment of multiple-drug resistant gram-negative infections Am J Health Syst Pharm. 62 2005 39 47 (Pubitemid 40394633)
30. S.K. Kasiakou, A. Michalopoulos, E.S. Soteriades, G. Samonis, G.J. Sermaides, and M.E. Falagas Combinaton therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis Antimicrob Agents Chemother. 49 2005 3136 3146 (Pubitemid 41060551)
31. A.S. Michalopoulos, S. Tsiodras, K. Rellos, S. Mentzelopoulos, and M.E. Falagas Colistin treatment in patients with ICU-adquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic Clin Microbiol Infect. 11 2005 115 121 (Pubitemid 40259694)
32. N. Markou, H. Apostolakos, C. Koumoudiou, M. Athanasiou, A. Koutsoukou, and I. Alamanos Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients Crit Care. 7 2003 R78 83
33. P.K. Linden, S. Kusne, K. Coley, P. Fontes, D.J. Kramer, and D. Paterson Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa Clin Infect Dis. 37 2003 e154 e160
34. S.P. Conway, M.N. Pond, A. Watson, C. Etherington, H.L. Robey, and M.H. Goldman Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystinc fibrosis Thorax. 52 1997 987 993 (Pubitemid 27514495)
35. A.S. Levin, A.A. Barone, J. Penco, M.V. Santos, I.S. Marinho, and E.A. Arruda Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clin Infect Dis. 28 1999 1008 1011 (Pubitemid 29203530)
36. A. Cascio, A. Conti, L. Sinardi, C. Iaria, F.F. Angileri, and G. Stassi Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature Int J Infect Dis. 14 2010 e572 e579
37. M.E. Jiménez-Mejías, C. Pichardo-Guerrero, F.J. Márquez-Rivas, D. Martín-Lozano, T. Prados, and J. Pachón Cerebroespinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of a multidrug-resistant Acinetobacter baumanii meningitis Eur J Clin Microbiol Infect Dis. 21 2002 212 214 (Pubitemid 34328007)
38. M.E. Jiménez-Mejías, B. Becerril, F.J. Márquez- Rivas, C. Pichardo, L. Cuberos, and J. Pachón Successful treatment of multidrug-resistant Acinetobacter baumanii meningitis with intravenous colistin sulfomethate sodium Eur J Clin Microbiol Infect Dis. 19 2000 970 971 (Pubitemid 32206335)
39. Z. Burkhary, W. Mahmood, A. Al-Khani, and H.M. Al-Abdely Treatment of nosocomial meningitis due to multidrug resistant Acinetobacter baumanii with intraventricular colistin Saudi Med. 50 2005 348 352
40. A. Michalopoulos, S. Kasiakou, E. Rosmarakis, and M. Falagas Cure of multidrug-resistant Acinetobacter baumanii bacteraemia with continuous intravenous infusion of colistin Scand J Infect Dis. 37 2005 142 145 (Pubitemid 40298169)
41. S.K. Kasiakou, K. Fragoulis, G. Tzagarakis, P. Mistidis, A. Kapaskelis, and M.E. Falagas Cure of multidrug-resistant Acinetobacter baumanii fixation device-related orthopedic infections in two patients with intravenous colistin Microb Drug Resist. 11 2005 287 289 (Pubitemid 41434175)
42. M.E. Falagas, P.I. Rafailidis, S.K. Kasiakou, P. Hatzopoulou, and A. Michalopoulos Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections Clin Microbiol Infect. 12 2006 1227 1230 (Pubitemid 44762527)
43. F. Timurkaynak, F. Can, O.K. Azap, M. Demirbilek, H. Arslan, and S.O. Karaman In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units Int J Antimicrob Agents. 27 2006 224 228 (Pubitemid 43246952)
44. J.Y. Song, J. Lee, J.Y. Heo, J.Y. Noh, W.J. Kim, and H.J. Cheong Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii Int J Antimicrob Agents. 32 2008 281 284
45. J. Li, and J.D. Turnidge Defining the dosage units for colistin and colistin methanosulfonate: urgent need for internacional harmonization Antimicrob Agents Chemother. 50 2006 4231 4232
46. J. Koch-Weser, V.W. Sidel, E.B. Federman, P. Kanarek, D.C. Finer, and A.E. Eaten Adverse effects on sodium colistimethate: manifestations and specific reaction rates during 317 courses of therapy Ann Intern Med. 72 1970 857 868
47. M.E. Evans, D.J. Feola, and R.P. Rapp Polymyxin b sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria Ann Pharmacother. 33 1999 960 967 (Pubitemid 29420995)
48. J.D. Hartzell, R. Neff, J. Ake, R. Howard, S. Olson, and K. Paolino Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center Clin Infect Dis. 48 2009 1724 1728
49. M.D. Reed, R.C. Stern, M.A. O'Riordan, and J.L. Blumer The pharmacokinetics of colistin in patients with cystic fibrosis J Clin Pharmacol. 41 2001 645 654 (Pubitemid 32493359)
50. J.A. Bosso, C.A. Liptak, D.K. Seilheimer, and G.M. Harrison Toxicity of colistin in cystic fibrosis patients Ann Pharmacother. 25 1991 1168 1170
51. M.E. Falagas, and S.K. Kasiakou Toxicity of polymyxins: a systematic review of the evidence from old and recent studies Crit Care. 10 2006 R27
52. J.A. Kellum, R. Bellomo, and C. Ronco Definition and classification of acute kidney injury Nephron Clin Pract. 109 2008 c182 c187
53. S.J. Wallace, J. Li, R.L. Nation, C.R. Rayner, D. Taylor, and D. Middleton Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens Antimicrob Agents Chemother. 52 2008 1159 1161 (Pubitemid 351358406)
54. M.E. Falagas, M. Rizos, I.A. Bliziotis, K. Rellos, S.K. Kasiakou, and A. Michalopoulos Toxicity after prolonged (more than four weeks) administration of intravenous colistin BMC Infect Dis. 5 2005 1
55. L. Renard, P. Sanders, and M. Laurentie Pharmacokinetics of colistin sulfate administered by intravenous and intramuscular routes in the calf Ann Rech Vet. 22 1991 287 394
56. G. Ziv, J.F. Nouws, and C.A. van Ginneken The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves J Vet Pharmacol Ther. 5 1982 45 58
57. A.A. Al-Khayyat, and A.L. Aronson Pharmacologic and toxicologic studies with the polymyxins. II comparative pharmacologic studies of the sulfate and methanesulfonate salts of polymyxin B and colistin in dogs Chemotherapy. 19 1973 82 97
58. D. Plachouras, M. Karvanen, L.E. Friberg, E. Papadomichelajkis, A. Antoniadou, and I. Tsangaris Population pharmacokinetic analysis of colistin methanesulfonate and colistin alter intravenous adminsitrations in critically ill patients with infections caused by gram-negative bacteria Antimicrob Agents Chemother. 53 2009 3430 3436
59. P. Leroy, D. Decolin, S. Nicolas, P. Archimbault, and A. Nicolas Residue determination of two co-administered antibacterial agents-cephalexin and colistin- in calf tissues using high-performance liquid chromatography J Pharm Biomed Anal. 7 1989 1837 1846 (Pubitemid 20253618)
60. A.H. Thomas, J.M. Thomas, and I. Holloway Microbiological and chemical analysis of polymyxin B and polymyxin E (colistin) sulfates Analyst. 105 1980 1068 1075 (Pubitemid 11219410)
61. T. Kitagawa, W. Ohtani, Y. Maeno, K. Fujiwara, and Y. Kimura Sensitive enzyme immunoassay of colistin and its application to detect residual colistin in rainbow trout tissue J Assoc Off Anal Chem. 68 1985 661 664 (Pubitemid 16220085)
62. H.K. Kristensen, and S.H. Hansen Separation of polymxins by micellar electrokinetic capillary chromatography J Chromatogr A. 628 1993 309 315 (Pubitemid 23025250)
63. J. Li, R.L. Milne, R.L. Nation, J.D. Turnidge, K. Coulthard, and D.W. Jonson A simple method for the assay of colistin in human plasma, using pre-column derivatization with the 9-fluorenylmethyl chloroformate in solid-phase extracton cartridges and reversed-phase high-performance liquid chromatography J Chromatog B. 761 2001 167 175 (Pubitemid 32817106)
64. P. Gobin, F. Lemaitre, S. Marchand, W. Couet, and J.C. Olivier Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry Antimicrob Ag Chemother. 54 2010 1941 1948
65. D.N. Mackay, and D. Kaye Serum concentration of colistin in patients with normal and impaired renal function N Engl J Med. 270 1964 394 397
66. W.W. Wright, and H. Welch Chemical, biological and clinical observations on colistin Antibiot Annual. 7 1959/1960 61 74
67. N.J. Goodwin, and E.A. Friedman The effects of renal impairment, peritoneal diálisis, and hemodiálisis on serum sodium colistimethate levels Ann Intern Med. 68 1968 984 994
68. D.J. Price, and D.I. Graham Effects of large doses of colistin sulphomethate sodium on renal function Br Med J. 28 1970 525 527
69. J. Froman, L. Gross, and S. Curatola Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals J Urol. 103 1970 210 214
70. R. Imberti, M. Cusato, P. Villani, L. Carnevale, G.A. Lotti, and M. Langer Steady-state pharmacokinetics and bronchoalveolar lavage concentration of colistin in critically ill patients after intravenous colistin methanesulphonate administration Chest 138 2010 1333 1339
71. S. Marchand, J.P. Frat, F. Petitpas, F. Lemaitre, P. Gobin, and R. Robert Removal of colistin during intermittent haemodialysis in two critically ill patients J Antimicrob Chemother. 65 2010 1836 1837
72. S.L. Markantonis, N. Markou, M. Fousteri, N. Sakellaridis, S. Karatzas, and I. Alamanos Penetration of colistin into cerebrospinal fluid Antimicrob Agents Chemother. 53 2009 4907 4910
73. N. Markou, S.L. Markantonis, E. Dimitrakis, D. Panidis, E. Boutzouka, and S. Karatzas Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study Clin Ther. 30 2008 143 151 (Pubitemid 351834728)
74. F. Ratjen, E. Rietschel, D. Kasel, R. Schwiertz, K. Starke, and H. Beier Pharmacokinetics of inhaled colistin in patients with cystic fibrosis J Antimicrob Chemother. 57 2006 306 311 (Pubitemid 43160174)
75. J. Li, C.R. Rayner, R.L. Nation, R. Deans, R. Boots, and N. Widdecombe Pharmacokinetics of colistins methanosulfonate and colistin in a critically ill patients receiving continuous venovenous hemodiafiltration Antimicrob Agents Chemother. 49 2005 4814 4815 (Pubitemid 41552630)
76. J. Li, K. Coulthard, R.W. Milne, R.L. Nation, D. Conway, and D. Peckham Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fribrosis J Antimicrob Chemother. 52 2003 987 992 (Pubitemid 38008420)
77. P.P. Le Brun, A.I. De Graaf, and A. Vinks High-performance liquid chromatographic method for the determination of colistin in serum Ther. Drug Monit. 22 2000 589 593
78. D. Decolin, P. Leroy, A. Nicolas, and P. Archimbault Hyphenated liquid chromatographic method for the determination of colistin residues in bovine tissues J Chromatogr Sci. 35 1997 557 564 (Pubitemid 127477135)
79. C.M. Kunin, and A. Bugg Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body J Infect Dis. 124 1971 394 400
80. N.J. Goodwin Colistin and sodium colistimethate Med Clin North Am. 54 1970 1267 1276
81. S. Gupta, D. Govil, P.N. Kakar, O. Prakash, D. Arora, and S. Das Colistin and polymyxin B: the re-emergence Indian J Crit Care Med. 13 2009 49 53
82. R. Maviglia, R. Nestorini, and M.A. Pennisi Role of old antibiotics in multidrug resistant bacterial infections Current Drug Targets. 10 2009 895 905
83. P.J. Bergen, J.B. Bulitta, A. Forrest, B.T. Tsuji, J. Li, and R.L. Nation Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model Antimicrob Agents Chemother. 54 2010 3783 3789
84. J. Li, R.W. Milne, R.L. Nation, J.D. Turnidge, T.C. Smeaton, and K. Coulthard Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration Antimicrob Agents Chemother. 47 2003 1766 1770 (Pubitemid 36548571)
85. S. Marchand, I. Lamarche, P. Gobin, and W. Couet Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses J Antimicrob Chemother. 65 2010 1753 1758
86. Agencia Española de Medicamentos y Productos Sanitarios. Disponible en: https://sinaem4.agemed.es/consaem/especialidad.do?metodo= verFichaWordPdf&codigo=66292&formato=pdf&formulario=FICHAS
87. P.A. Greenberg, and J.P. Sanford Removal and absorption of antibiotics in patients with renal failure undergoing peritoneal dialysis. Tetracycline, chloramphenicol, kanamycin, and colistimethate Ann Intern Med. 66 1967 465 470
88. N.M. Byrne, P.M. Keavey, J.D. Perry, F.K. Gould, and D.A. Spencer Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis Arch Dis Child. 88 2003 715 718 (Pubitemid 36930311)
89. A. Sadfar Feasibility of aerosolized colistin in the era of escalating drug-resistant Pseudomonas pneumonia. Pressing need for validation clinical trials Intensive Care Med. 36 2010 1110 1111
90. P. Rattanaumpawan, J. Lorsutthitham, P. Ungprasert, N. Angkasekwinai, and V. Thamlikitkul Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria J Antimicrob Chemother. 65 2010 2645 2649
91. D.P. Kofteridis, C. Alexopoulou, A. Valachis, S. Maraki, D. Dimopoulou, and D. Georgopoulos Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study Clin Infect Dis. 51 2010 1238 1244
92. A.P. MacGowan, and R. Wise Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests J Antimicrob Chemother. 48 suppl 1 2001 17 28
93. M. Knoch, and M. Keller The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems Expert Opin Drug Deliv. 2 2005 377 390 (Pubitemid 41130890)
94. B.W. Gunderson, K.H. Ibrahim, L.B. Hovde, T.L. Fromm, M.D. Reed, and J.C. Rotschafer Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model Antimicrob Agents Chemother. 47 2003 905 909 (Pubitemid 36254214)
95. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational suplement. Document M100-S16. Clinical and Laboratory Standards Institute; Wayne, PA: 2006.
96. European Committee on Antimicrobial Susceptibility Testing. 19 June 2008. Clinical breakpoints. Disponible en: http:/www.srga.org/eucastwt/MICTAB/ MICmiscellaneous.html/. European Committee on Antimicrobial Susceptibility testing.
97. G.L. Daikos, A. Skiada, J. Pavleas, C. Vafiadi, K. Salatas, and P. Tofas Serum bactericidal activity of three different dosing regimens of colistin with implications for optimum clinical use J Chemother. 22 2010 175 178
98. J. Molina, E. Cordero, and J. Pachón New information about the polymyxin/colistin class of antibiotics Expert Opin Pharmacother. 10 2009 2811 2828
99. Ketthireddy S, Lee DG, Murakami Y, Stamstad T, Andes DR, Craig WA. In vivo pharmacodynamics of colistin against Pseudomonas aeruginosa in thighs of neutropenic mice (abstract A-4, p1). Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC);September 17-20; 2007. Chicago, Illinois: American Society for Microbiology; 2007.
100. R.J. Owen, J. Li, R.L. Nation, and D. Spelman In vitro pharmacodynamics of colistin against Acinetobacter baumannii isolated J Antimicrob Chemother. 59 2007 473 477 (Pubitemid 47073453)
101. P.J. Bergen, J. Li, R.L. Nation, J.D. Turnidge, K. Coulthard, and R.W. Milne Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model J Antimicrob Chemother. 61 2008 636 642 (Pubitemid 351321139)
102. R.V. Dudhani, J.D. Turnidge, K. Coulthard, R.W. Milne, C.R. Rayner, and J. Li Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models Antimicrob Agents Chemother. 54 2010 1117 1124
103. R.V. Dudhani, J.D. Turnidge, R.L. Nation, and J. Li fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models J Antimicrob Chemother. 65 2010 1984 1990
104. J.B. Bulitta, J.C. Yang, L. Yohonn, N.S. Ly, S.V. Brown, and R.E. D'Hondt Attenuation of colistin bactericidal activity by high inocolum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model Antimicrob Ag Chemother. 54 2010 2051 2052
105. S.D. Davis Activity of gentamicin, tobramycin, polymyxin B, and colistimethate in mouse protection tests with Pseudomonas aeruginosa Antimicrob Agents Chemother. 8 1975 50 53
106. C.H. Tan, and R.L. Nation Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model Antimicrob Agents Hemother. 51 2007 3413 3415 (Pubitemid 350067568)